Dexamethasone and long-term outcome in adults with bacterial meningitis

Annals of Neurology

Volumn 60, Issue 4, 2006, Pages 456-468

  Weisfelt, Martijn ^a   Hoogman, Martine ^a   Van De Beek, Diederik ^a   De Gans, Jan ^a   Dreschler, Wouter A ^a   Schmand, Ben A ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PLACEBO;

ADULT; ARTICLE; AUDIOLOGY; BACTERIAL MENINGITIS; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EVALUATION; FEMALE; FOLLOW UP; HEARING LOSS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PHYSICAL DISABILITY; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; DATA INTERPRETATION, STATISTICAL; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEARING TESTS; HUMANS; INTELLIGENCE TESTS; LANGUAGE; MALE; MEMORY; MENINGITIS, BACTERIAL; MENINGITIS, MENINGOCOCCAL; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

EID: 33750578407     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20944     Document Type: Article

References (38)

1. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-1859.
2. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med 2006;354:44-53.
3. Weisfelt M, van de Beek D, Spanjaard L, et al. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006;5: 123-129.
4. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21-28.
5. van de Beek D, Schmand B, de Gans J, et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002;186:1047-1052.
6. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-1556.
7. van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis 2004;4:139-143.
8. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-1284.
9. Sapolsky RM, Pulsinelli WA. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 1985; 229:1397-1400.
10. Leib SL, Heimgartner C, Bifrare YD, et al. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res 2003;54: 353-357.
11. van de Beek D, Weisfelt M, Hoogman M, et al. Neuropsychological sequelae of bacterial meningitis: alcoholism and adjunctive dexamethasone therapy. Brain 2006;129:E46.
12. Weisfelt M, van de Beek D, de Haan RJ, de Gans J. Dexamethasone and prognostic factors in adults with bacterial meningitis. J Neurol 2006;253:570-573.
13. Weisfelt M, de Gans J, van der Poll T, van de Beek D. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol 2006;5:332-342.
14. Kastenbauer S. Pneumococcal meningitis: a 21st century perspective. Lancet Neurol 2006;5:104-105.
15. Jennet B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-484.
16. Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 1984;311:869-874.
17. Luteijn F, van der Ploeg F. Groningen intelligentie test. Lisse, the Netherlands: Swets and Zeitlinger, 1983.
18. Schmand B, Lindeboom J, van Harskamp F. De Nederlandse leestest voor volwassenen. Lisse, the Netherlands: Swets and Zeitlinger, 1992.
19. Lezak MD, Howieson BD, Loring DW. Neuropsychological assessment. 4th ed. New York: Oxford University Press, 2004.
20. Wilson B, Cockburn J, Baddeley A. Rivermead behavioural memory test. Oxford: Thames Valley Test Company, 1985.
21. Wechsler D. Wechsler Adult Intelligence Scale-Revised WAIS-R: test manual. New York: Psychological Corporation, 1981.
22. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
23. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-164.
24. van der Zee K, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36. Groningen, the Netherlands: Groningen University, 1993.
25. Baser CA, Ruff RM. Construct validity of the San Diego Neuropsychological Test Battery. Arch Clin Neuropsychol 1987;2: 13-32.
26. Mitrushina MN, Boone KB, D'Eli L. Handbook of normative data for neuropsychological assessment. New York: Oxford University Press, 1999.
27. Weisfelt M, van de Beek D, Hoogman M, et al. Cognitive outcome in adults with moderate disability after pneumococcal meningitis. J Infect 2006;52:433-439.
28. McIntosh LJ, Sapolsky RM. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp Neurol 1996;141: 201-206.
29. Mitchell IJ, Cooper AJ, Griffiths MR, Barber DJ. Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis? Neuroscience 1998;84:489-501.
30. Haynes LE, Griffiths MR, Hyde RE, et al. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders. Neuroscience 2001;104:57-69.
31. Zysk G, Bruck W, Gerber J, et al. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996;55:722-728.
32. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-1313.
33. Schmidt H, Heimann B, Djukic M, et al. Neuropsychological sequelae of bacterial and viral meningitis. Brain 2006;129: 333-345.
34. Merkelbach S, Sittinger H, Schweizer I, Muller M. Cognitive outcome after bacterial meningitis. Acta Neurol Scand 2000; 102:118-123.
35. Bohr V, Rasmussen N, Hansen B, et al. Pneumococcal meningitis: an evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae. J Infect 1985;10:143-157.
36. Irazuzta J, Pretzlaff RK, Courten-Myers G, et al. Dexamethasone decreases neurological sequelae and caspase activity. Intensive Care Med 2005;31:146-150.
37. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis 1989;160:818-825.
38. Martins MR, Barichello T, Ritter C, et al. Dexamethasone therapy and memory performance. Intensive Care Med 2005;31: 1001.